(0.16%) 5 139.50 points
(0.11%) 38 482 points
(0.24%) 17 889 points
(-0.25%) $83.64
(1.61%) $1.954
(0.13%) $2 350.20
(0.64%) $27.71
(1.55%) $936.40
(-0.15%) $0.933
(-0.29%) $10.99
(-0.30%) $0.798
(1.20%) $92.97
@ $20.55
发出时间: 15 Feb 2024 @ 04:28
回报率: -29.10%
上一信号: Feb 14 - 22:30
上一信号:
回报率: -2.70 %
Live Chart Being Loaded With Signals
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally...
Stats | |
---|---|
今日成交量 | 301 183 |
平均成交量 | 427 456 |
市值 | 598.31M |
EPS | $0 ( 2024-02-26 ) |
下一个收益日期 | ( $-0.290 ) 2024-05-06 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -12.89 |
ATR14 | $0.0180 (0.12%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-02 | Recupero Anthony J | Sell | 1 555 | Common Stock |
2024-04-02 | Recupero Anthony J | Sell | 1 752 | Common Stock |
2024-04-03 | Recupero Anthony J | Sell | 920 | Common Stock |
2024-04-02 | Maheshwari Anshul | Sell | 1 140 | Common Stock |
2024-04-02 | Maheshwari Anshul | Sell | 1 285 | Common Stock |
INSIDER POWER |
---|
20.99 |
Last 100 transactions |
Buy: 453 308 | Sell: 383 933 |
音量 相关性
SI-BONE Inc 相关性 - 货币/商品
SI-BONE Inc 财务报表
Annual | 2023 |
营收: | $138.89M |
毛利润: | $109.42M (78.78 %) |
EPS: | $-1.130 |
FY | 2023 |
营收: | $138.89M |
毛利润: | $109.42M (78.78 %) |
EPS: | $-1.130 |
FY | 2022 |
营收: | $106.41M |
毛利润: | $90.70M (85.24 %) |
EPS: | $-1.840 |
FY | 2021 |
营收: | $90.15M |
毛利润: | $79.72M (88.43 %) |
EPS: | $-1.697 |
Financial Reports:
No articles found.
SI-BONE Inc
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。